My watch list  

33 Current news of Pfizer


You can refine your search further. Select from the filter options on the left to narrow down your results.

Pfizer, GSK, and Siemens form R&D Consortium with A*STAR’s Institute of Chemical & Engineering Sciences

New programme aims to help companies increase productivity with technology solutions for pharmaceutical and chemical sectors


Pfizer Asia Pacific Pte. Ltd, Glaxo Wellcome Manufacturing Pte. Ltd. and Siemens Pte. Ltd, have signed on as founding members of a new A*STAR R&D Consortium Programme - Innovative Processing of Specialties and Pharmaceuticals (iPSP). Launched by A*STAR’s Institute of Chemical and Engineering ...


image description
Chemists synthesize herbal alkaloid


The club moss Lycopodium serratum is a creeping, flowerless plant used in homeopathic medicine to treat a wide variety of ailments. It contains a potent brew of alkaloids that have attracted considerable scientific and medical interest. However, the plant makes many of these compounds in ...


EPA Honors Pfizer for Reducing Greenhouse Gas Emissions

Company Exceeds Initial Goal - Pledges 20 Percent Reduction Between Now and 2012


The U.S. Environmental Protection Agency (EPA) honored Pfizer Inc in recognition of the company’s award-winning Energy and Climate Change Program, which reduced total greenhouse gas emissions by 43 percent per million dollars of revenue from 2000 to 2007. These reductions, which exceeded ...


Hikal signs a manufacturing agreement with Pfizer


Hikal Ltd. announced that it has completed a contract manufacturing agreement for supply of active pharmaceutical ingredients (API's) with Pfizer Inc. "We are extremely pleased to be selected as a long term contract manufacturer by Pfizer", said Jai Hiremath, Vice Chairman & Managing Director of ...


Pfizer and Taisho Finalize Agreement for Novel Schizophrenia Drug Candidate


Pfizer Inc and Taisho Pharmaceutical Co., Ltd. have signed a definitive agreement, which replaces the letter of intent previously signed between the companies, for worldwide (excluding Japan) collaboration to research, develop and commercialize TS-032, a new schizophrenia drug candidate ...


Pfizer to Acquire Coley Pharmaceutical Group

Acquisition Will Expand Pfizer's Investment in Vaccines


Pfizer Inc announced it has entered into an agreement to acquire Coley Pharmaceutical Group, Inc., a publicly-held biopharmaceutical company specializing in vaccine adjuvant technology and a new class of immunomodulatory drug candidates designed to fight cancers, allergy and asthma disorders, and ...


Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program

Companies Will Jointly Conduct Phase III Development and Commercialization of DGAT-1 Inhibitor Compounds


Pfizer Inc and Bristol-Myers Squibb Company announced that they have finalized a definitive agreement for the worldwide collaboration to research, develop and commercialize DGAT-1 inhibitors. Pfizer's DGAT-1 discovery program includes advanced pre-clinical compounds with potential applications ...


High Court in Dublin Rules in Pfizer's Favor in Patent Case, Lipitor Protected from Generic Competition until 2011


Pfizer Inc said that the High Court in Dublin, Ireland has ruled that the basic patent covering atorvastatin - the active ingredient in Lipitor - would be infringed by a competitor product from generics manufacturer Ranbaxy. The decision, which is subject to a possible appeal, prevents Ranbaxy ...


Pfizer Says Research and Development Head John LaMattina Will Retire This Year

Company to Focus on Accelerating Development and Commercialization of Strong Early- and Mid-Stage Pipeline


Pfizer said that the President of Pfizer Global Research and Development, Dr. John LaMattina, who made many important contributions to the Company's research division throughout his 30-year career, will retire from Pfizer by the end of this year. The company will begin a search both inside and ...


Pfizer Board of Directors Elects Constance J. Horner to Serve as Lead Director


Pfizer said that Constance J. Horner, a member of the company's Board of Directors since 1993, has been elected lead director effective February 23. She succeeds Dr. Stanley O. Ikenberry, who has announced plans to retire from the board effective March 22, 2007 in accordance with Pfizer's ...


Page 1 From 4
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE